Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Phloroglucinol Inhibits the in vitro Differentiation Potential of CD34 Positive Cells into Endothelial Progenitor Cells

  • Kwon, Yi-Hong (Department of Biomedical Science, Laboratory for Functional Foods & Nutrigenomics, Department of Food Science and Biotechnology, CHA University) ;
  • Lee, Jun-Hee (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yangsan Hospital) ;
  • Jung, Seok-Yun (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yangsan Hospital) ;
  • Kim, Jae-Won (Department of Biomedical Science, Laboratory for Functional Foods & Nutrigenomics, Department of Food Science and Biotechnology, CHA University) ;
  • Lee, Sang-Hun (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yangsan Hospital) ;
  • Lee, Dong-Hyung (Department of Obstetrics and Gynecology, Pusan National University College of Medicine and Medical Research Institute, Pusan National University) ;
  • Lee, Kyu-Sup (Department of Obstetrics and Gynecology, Pusan National University College of Medicine and Medical Research Institute, Pusan National University) ;
  • Lee, Boo-Yong (Department of Biomedical Science, Laboratory for Functional Foods & Nutrigenomics, Department of Food Science and Biotechnology, CHA University) ;
  • Kwon, Sang-Mo (Laboratory for Vascular Medicine & Stem Cell Biology, Research Institute of Convergence of Biomedical Science and Technology, Department of Physiology, Pusan National University Yangsan Hospital)
  • Received : 2011.10.12
  • Accepted : 2011.11.23
  • Published : 2012.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Inhibiting the bioactivities of circulating endothelial progenitor cells (EPCs) results in significant inhibition of neovessel formation during tumor angiogenesis. To investigate the potential effect of phloroglucinol as an EPC inhibitor, we performed several in vitro functional assays using $CD34^+$ cells isolated from human umbilical cord blood (HUCB). Although a high treatment dose of phloroglucinol did not show any cell toxicity, it specifically induced the cell death of EPCs under serum free conditions through apoptosis. In the EPC colony-forming assay (EPC-CFA), we observed a significant decreased in the small EPC-CFUs for the phloroglucinol group, implying that phloroglucinol inhibited the early stage of EPC commitment. In addition, in the in vitro expansion assay using $CD34^+$ cells, treatment with phloroglucinol was shown to inhibit endothelial lineage commitment, as demonstrated by the decrease in endothelial surface markers of EPCs including $CD34^+$, $CD34^+/CD133^+$, $CD34^+/CD31^+$ and $CD34^+/CXCR4^+$. This is the first report to demonstrate that phloroglucinol can inhibit the functional bioactivities of EPCs, indicating that phloroglucinol may be used as an EPC inhibitor in the development of biosafe anti-tumor drugs that target tumor angiogenesis.

Keywords

References

  1. Cragg, G. M. and Newman, D. J. (2005) Plants as a source of anticancer agents. J. Ethnopharmacol. 100, 72-79. https://doi.org/10.1016/j.jep.2005.05.011
  2. Fang, J., Zhou, Q., Liu, L. Z., Xia, C., Hu, X., Shi, X. and Jiang, B. H. (2007) Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis. 28, 858-864.
  3. Folkman, J. (1976) The vascularization of tumors. Sci. Am. 234, 58- 64, 70-73.
  4. Gupta, P., Kumar, R., Garg, P. and Singh, I. P. (2010) Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase. Bioorg. Med. Chem. Lett. 20, 4427-4431. https://doi.org/10.1016/j.bmcl.2010.06.057
  5. Hicklin, D. J. and Ellis, L. M. (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23, 1011-1027.
  6. Ingram, D. A., Mead, L. E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., Pollok, K., Ferkowicz, M. J., Gilley, D. and Yoder, M. C. (2004) Identifi cation of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 104, 2752-2760. https://doi.org/10.1182/blood-2004-04-1396
  7. Kang, K. A., Lee, K. H., Chae, S., Zhang, R., Jung, M. S., Ham, Y. M., Baik, J. S., Lee, N. H. and Hyun, J. W. (2006) ytoprotective effect of phloroglucinol on oxidative stress induced cell damage via catalase activation. J. Cell Biochem. 97, 609-620. https://doi.org/10.1002/jcb.20668
  8. Kwon, S. M., Lee, Y. K., Yokoyama, A., Jung, S. Y., Masuda, H., Kawamoto, A., Lee, Y. M. and Asahara, T. (2011) Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J. Mol. Cell. Cardiol. 51, 308-317. https://doi.org/10.1016/j.yjmcc.2011.04.007
  9. Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P. and Young, P. P. (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 20, 95-97. https://doi.org/10.1096/fj.04-3669com
  10. Masuda, H., Alev, C., Akimaru, H., Ito, R., Shizuno, T., Kobori, M., Horii, M., Ishihara, T., Isobe, K., Isozaki, M., Itoh, J., Itoh, Y., Okada, Y., McIntyre, B. A., Kato, S. and Asahara, T. (2011) Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ. Res. 109, 20-37. https://doi.org/10.1161/CIRCRESAHA.110.231837
  11. Park, S. J., Ahn, G., Lee, N. H., Park, J. W., Jeon, Y. J. and Jee, Y. (2011) Phloroglucinol (PG) purifi ed from Ecklonia cava attenuates radiation-induced apoptosis in blood lymphocytes and splenocytes. Food Chem. Toxicol. 49, 2236-2242. https://doi.org/10.1016/j.fct.2011.06.021
  12. Prater, D. N., Case, J., Ingram, D. A. and Yoder, M. C. (2007) Working hypothesis to redefi ne endothelial progenitor cells. Leukemia. 21, 1141-1149. https://doi.org/10.1038/sj.leu.2404676
  13. Shweiki, D., Neeman, M., Itin, A. and Keshet, E. (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose defi ciency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA. 92, 768-772. https://doi.org/10.1073/pnas.92.3.768
  14. Singh, I. P., Sidana, J., Bansal, P. and Foley, W. J. (2009) Phloroglucinol compounds of therapeutic interest: global patent and technology status. Expert. Opin. Ther. Pat. 19, 847-866. https://doi.org/10.1517/13543770902916614
  15. Suuronen, E. J., Veinot, J. P., Wong, S., Kapila, V., Price, J., Griffi th, M., Mesana, T. G. and Ruel, M. (2006) Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation. 114 (1 Suppl), I138-I144.
  16. Toi, M., Inada, K., Suzuki, H. and Tominaga, T. (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat. 36, 193-204. https://doi.org/10.1007/BF00666040
  17. Vajkoczy, P., Blum, S., Lamparter, M., Mailhammer, R., Erber, R., Engelhardt, B., Vestweber, D. and Hatzopoulos, A. K. (2003) Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J. Exp. Med. 197, 1755-1765. https://doi.org/10.1084/jem.20021659
  18. Yi, T., Cho, S. G., Yi, Z., Pang, X., Rodriguez, M., Wang, Y., Sethi, G., Aggarwal, B. B. and Liu, M. (2008) Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol. Cancer Ther. 7, 1789-1796. https://doi.org/10.1158/1535-7163.MCT-08-0124

Cited by

  1. Effect of Initial Substrate Concentrations and Temperature on the Oscillatory Behavior of Phloroglucinol-Based Belousov–Zhabotinsky Reaction vol.86, pp.2, 2013, https://doi.org/10.1246/bcsj.20120217
  2. Two-Cell Spheroid Angiogenesis Assay System Using Both Endothelial Colony Forming Cells and Mesenchymal Stem Cells vol.26, pp.5, 2018, https://doi.org/10.4062/biomolther.2018.134
  3. CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity vol.40, pp.18, 2012, https://doi.org/10.1038/s41388-021-01758-w